$1.42 Billion is the total value of Ikarian Capital, LLC's 209 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 59.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $128,741,000 | – | 300,000 | +100.0% | 9.07% | – |
| XBI | New | SPDR SER TRput | $81,713,000 | – | 650,000 | +100.0% | 5.75% | – |
| RETA | Buy | REATA PHARMACEUTICALS INCput | $47,423,000 | +91.6% | 471,400 | +169.5% | 3.34% | +66.9% |
| BIIB | Sell | BIOGEN INCcall | $47,402,000 | -49.3% | 167,500 | -38.0% | 3.34% | -55.8% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB Lcall | $46,212,000 | +97.4% | 421,900 | +68.8% | 3.25% | +72.0% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEWcall | $42,741,000 | +113.0% | 791,600 | +31.9% | 3.01% | +85.6% |
| UNH | New | UNITEDHEALTH GROUP INCcall | $39,074,000 | – | 100,000 | +100.0% | 2.75% | – |
| XBI | New | SPDR SER TRcall | $37,712,000 | – | 300,000 | +100.0% | 2.66% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INCcall | $33,949,000 | +2.3% | 179,800 | -8.1% | 2.39% | -10.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS INCcall | $33,449,000 | +760.5% | 361,700 | +623.4% | 2.36% | +650.0% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEWput | $28,084,000 | +5149.3% | 520,200 | +3151.2% | 1.98% | +4500.0% |
| CMPS | New | COMPASS PATHWAYS PLCcall | $25,330,000 | – | 848,100 | +100.0% | 1.78% | – |
| CRSP | Sell | CRISPR THERAPEUTICS AGput | $22,084,000 | -31.8% | 197,300 | -1.4% | 1.56% | -40.6% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $21,897,000 | – | 526,500 | +100.0% | 1.54% | – |
| RFL | New | RAFAEL HLDGS INCcall | $17,833,000 | – | 580,400 | +100.0% | 1.26% | – |
| GOSS | Buy | GOSSAMER BIO INC | $16,995,000 | +99.6% | 1,351,933 | +29.0% | 1.20% | +74.0% |
| KOD | Buy | KODIAK SCIENCES INCcall | $16,115,000 | +139.7% | 167,900 | +132.2% | 1.14% | +108.6% |
| ALLK | Buy | ALLAKOS INCcall | $15,964,000 | +129.5% | 150,800 | +85.0% | 1.12% | +100.0% |
| KRYS | New | KRYSTAL BIOTECH INCput | $15,272,000 | – | 292,500 | +100.0% | 1.08% | – |
| KRYS | New | KRYSTAL BIOTECH INCcall | $14,740,000 | – | 282,300 | +100.0% | 1.04% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $14,600,000 | +19.4% | 270,431 | -26.0% | 1.03% | +4.0% |
| NVAX | New | NOVAVAX INCcall | $14,511,000 | – | 70,000 | +100.0% | 1.02% | – |
| CABA | Buy | CABALETTA BIO INC | $14,445,000 | +77.3% | 1,187,898 | +25.4% | 1.02% | +54.6% |
| XFOR | Sell | X4 PHARMACEUTICALS INC | $13,437,000 | -24.0% | 2,539,917 | -6.6% | 0.95% | -33.8% |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INCcall | $13,328,000 | – | 200,000 | +100.0% | 0.94% | – |
| CRTX | New | CORTEXYME INCcall | $13,024,000 | – | 142,100 | +100.0% | 0.92% | – |
| RFL | New | RAFAEL HLDGS INCput | $12,716,000 | – | 413,800 | +100.0% | 0.90% | – |
| SRRA | Buy | SIERRA ONCOLOGY INC | $12,569,000 | +18.3% | 573,380 | +5.2% | 0.88% | +3.0% |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $12,384,000 | – | 70,000 | +100.0% | 0.87% | – |
| IMTX | Buy | IMMATICS N.V | $11,479,000 | +339.3% | 883,046 | +292.2% | 0.81% | +282.9% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $11,455,000 | – | 347,545 | +100.0% | 0.81% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INCput | $11,385,000 | -40.0% | 345,400 | +15.1% | 0.80% | -47.7% |
| MRK | New | MERCK & CO INCcall | $11,266,000 | – | 150,000 | +100.0% | 0.79% | – |
| RETA | New | REATA PHARMACEUTICALS INCcall | $11,027,000 | – | 109,600 | +100.0% | 0.78% | – |
| EDIT | New | EDITAS MEDICINE INCput | $10,438,000 | – | 254,100 | +100.0% | 0.74% | – |
| TCON | Sell | TRACON PHARMACEUTICALS INC | $10,415,000 | -40.9% | 2,691,110 | -0.9% | 0.73% | -48.6% |
| CCXI | Sell | CHEMOCENTRYX INCput | $10,261,000 | -20.8% | 600,000 | -38.0% | 0.72% | -30.9% |
| CCXI | Buy | CHEMOCENTRYX INCcall | $10,260,000 | +246.5% | 600,000 | +171.2% | 0.72% | +202.1% |
| MIST | Sell | MILESTONE PHARMACEUTICALS IN | $9,993,000 | -8.3% | 1,750,043 | -11.6% | 0.70% | -20.1% |
| DRNA | New | DICERNA PHARMACEUTICALS INCcall | $9,952,000 | – | 493,600 | +100.0% | 0.70% | – |
| INBX | Buy | INHIBRX INC | $9,654,000 | +4248.6% | 289,850 | +3489.0% | 0.68% | +3677.8% |
| MGNX | Buy | MACROGENICS INCcall | $9,340,000 | +15.9% | 446,000 | +48.7% | 0.66% | +1.1% |
| BIIB | Sell | BIOGEN INC | $9,123,000 | -79.1% | 32,243 | -74.4% | 0.64% | -81.8% |
| ZGNX | Sell | ZOGENIX INCcall | $8,968,000 | -38.9% | 590,400 | -30.5% | 0.63% | -46.8% |
| ARNA | Sell | ARENA PHARMACEUTICALS INCcall | $8,854,000 | -13.5% | 148,700 | -0.9% | 0.62% | -24.7% |
| XENE | Buy | XENON PHARMACEUTICALS INCcall | $8,353,000 | +150.5% | 546,700 | +205.2% | 0.59% | +117.8% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $7,890,000 | -16.3% | 211,670 | -8.3% | 0.56% | -27.0% |
| APLS | Sell | APELLIS PHARMACEUTICALS INCcall | $7,680,000 | -59.5% | 233,000 | -22.3% | 0.54% | -64.7% |
| PCVX | Sell | VAXCYTE INC | $7,486,000 | -25.8% | 295,111 | -34.1% | 0.53% | -35.3% |
| CMPS | Buy | COMPASS PATHWAYS PLCsponsored ads | $6,846,000 | +111.0% | 229,202 | +169.4% | 0.48% | +84.0% |
| INCY | Sell | INCYTE CORPcall | $6,789,000 | -59.6% | 98,700 | -50.6% | 0.48% | -64.9% |
| IGMS | New | IGM BIOSCIENCES INCcall | $6,576,000 | – | 100,000 | +100.0% | 0.46% | – |
| ELAN | New | ELANCO ANIMAL HEALTH INCcall | $6,378,000 | – | 200,000 | +100.0% | 0.45% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $6,152,000 | – | 92,344 | +100.0% | 0.43% | – |
| AYLA | New | AYALA PHARMACEUTICALS INC | $6,112,000 | – | 538,939 | +100.0% | 0.43% | – |
| AZN | New | ASTRAZENECA PLCcall | $6,006,000 | – | 100,000 | +100.0% | 0.42% | – |
| SCPH | Sell | SCPHARMACEUTICALS INC | $5,994,000 | -10.4% | 901,362 | -17.7% | 0.42% | -22.0% |
| FATE | FATE THERAPEUTICS INCput | $5,928,000 | -31.7% | 100,000 | 0.0% | 0.42% | -40.6% | |
| BCAB | Buy | BIOATLA INC | $5,782,000 | +94.4% | 196,400 | +179.9% | 0.41% | +69.6% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $5,767,000 | -51.6% | 377,438 | -41.1% | 0.41% | -57.9% |
| BCYC | New | BICYCLE THERAPEUTICS PLCcall | $5,408,000 | – | 130,000 | +100.0% | 0.38% | – |
| ODT | Sell | ODONATE THERAPEUTICS INC | $5,357,000 | -22.7% | 1,840,631 | -7.3% | 0.38% | -32.7% |
| ALDX | New | ALDEYRA THERAPEUTICS INCcall | $5,268,000 | – | 600,000 | +100.0% | 0.37% | – |
| LIFE | Buy | ATYR PHARMA INC | $5,105,000 | +248.5% | 562,246 | +87.4% | 0.36% | +204.2% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $4,963,000 | -24.2% | 1,112,669 | -1.5% | 0.35% | -34.2% |
| CMRX | Sell | CHIMERIX INC | $4,960,000 | -60.7% | 801,308 | -49.2% | 0.35% | -65.8% |
| OCUL | Sell | OCULAR THERAPEUTIX INCcall | $4,932,000 | -50.3% | 493,200 | -29.5% | 0.35% | -56.8% |
| WVE | New | WAVE LIFE SCIENCES LTD | $4,867,000 | – | 993,481 | +100.0% | 0.34% | – |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INCput | $4,833,000 | -7.1% | 196,000 | -2.0% | 0.34% | -19.2% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $4,681,000 | -8.6% | 281,765 | +34.3% | 0.33% | -20.3% |
| BLU | Sell | BELLUS HEALTH INC NEW | $4,572,000 | +45.5% | 744,616 | -26.3% | 0.32% | +26.8% |
| GLPG | Sell | GALAPAGOS NVspon adr | $4,544,000 | -67.2% | 86,865 | -56.6% | 0.32% | -71.5% |
| AUPH | New | AURINIA PHARMACEUTICALS INCcall | $4,426,000 | – | 200,000 | +100.0% | 0.31% | – |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $4,254,000 | -6.6% | 172,521 | -1.4% | 0.30% | -18.5% |
| MCRB | New | SERES THERAPEUTICS INC | $4,222,000 | – | 606,554 | +100.0% | 0.30% | – |
| FNCH | Sell | FINCH THERAPEUTICS GROUP INC | $4,106,000 | -10.2% | 315,732 | -2.9% | 0.29% | -21.9% |
| AVIR | New | ATEA PHARMACEUTICALS INCcall | $4,088,000 | – | 116,600 | +100.0% | 0.29% | – |
| New | RENOVACOR INC | $4,008,000 | – | 442,902 | +100.0% | 0.28% | – | |
| ALLK | Sell | ALLAKOS INCput | $3,960,000 | +23.1% | 37,400 | -0.8% | 0.28% | +7.3% |
| MGNX | Sell | MACROGENICS INC | $3,947,000 | -68.0% | 188,478 | -59.0% | 0.28% | -72.1% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $3,954,000 | +20.1% | 414,174 | +21.3% | 0.28% | +4.5% |
| FOLD | New | AMICUS THERAPEUTICS INCput | $3,854,000 | – | 403,500 | +100.0% | 0.27% | – |
| VSTM | Sell | VERASTEM INC | $3,780,000 | -33.4% | 1,227,371 | -12.0% | 0.27% | -42.0% |
| OVID | Sell | OVID THERAPEUTICS INC | $3,715,000 | -15.5% | 1,105,082 | -1.8% | 0.26% | -26.4% |
| LYRA | Sell | LYRA THERAPEUTICS INC | $3,688,000 | -26.5% | 403,450 | -35.4% | 0.26% | -36.0% |
| CRVS | Buy | CORVUS PHARMACEUTICALS INC | $3,666,000 | +1273.0% | 757,545 | +657.5% | 0.26% | +1072.7% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INCcall | $3,592,000 | – | 250,000 | +100.0% | 0.25% | – |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $3,568,000 | -60.4% | 544,819 | -59.8% | 0.25% | -65.5% |
| ISEE | New | IVERIC BIO INC | $3,516,000 | – | 216,519 | +100.0% | 0.25% | – |
| XENE | New | XENON PHARMACEUTICALS INCput | $3,515,000 | – | 230,000 | +100.0% | 0.25% | – |
| Sell | TRILLIUM THERAPEUTICS INCcall | $3,484,000 | +79.6% | 198,400 | -0.8% | 0.24% | +56.1% | |
| NXTC | Sell | NEXTCURE INC | $3,431,000 | -17.3% | 509,155 | -1.5% | 0.24% | -28.0% |
| IGMS | New | IGM BIOSCIENCES INC | $3,387,000 | – | 51,500 | +100.0% | 0.24% | – |
| ALLK | Sell | ALLAKOS INC | $3,337,000 | +23.3% | 31,526 | -0.5% | 0.24% | +7.3% |
| CLNN | Buy | CLENE INC | $3,342,000 | +150.7% | 489,321 | +312.8% | 0.24% | +117.6% |
| TARA | Sell | PROTARA THERAPEUTICS INC | $3,321,000 | -41.7% | 479,995 | -17.9% | 0.23% | -49.1% |
| TGTX | Sell | TG THERAPEUTICS INCput | $3,282,000 | -15.4% | 98,600 | -1.4% | 0.23% | -26.2% |
| ISEE | New | IVERIC BIO INCcall | $3,248,000 | – | 200,000 | +100.0% | 0.23% | – |
| VINC | Sell | VINCERX PHARMA INC | $3,219,000 | -41.9% | 199,057 | -53.4% | 0.23% | -49.3% |
| PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $3,196,000 | -5.6% | 99,560 | -0.4% | 0.22% | -17.9% |
| CMMB | Sell | CHEMOMAB THERAPEUTICS LTDsponsored ads | $3,160,000 | -42.8% | 285,264 | -1.8% | 0.22% | -50.1% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $3,144,000 | 0.0% | 500,642 | -4.6% | 0.22% | -13.0% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $3,131,000 | -83.8% | 27,968 | -76.6% | 0.22% | -86.0% |
| TCDA | Sell | TRICIDA INC | $3,113,000 | -7.0% | 670,771 | -13.5% | 0.22% | -19.2% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $3,109,000 | -12.5% | 310,110 | -3.9% | 0.22% | -23.7% |
| ACET | Buy | ADICET BIO INC | $3,077,000 | +138.3% | 392,418 | +212.6% | 0.22% | +108.7% |
| ARKG | ARK ETF TRgenomic rev etf | $3,061,000 | -19.2% | 40,961 | 0.0% | 0.22% | -29.4% | |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $2,934,000 | -35.4% | 629,384 | -2.3% | 0.21% | -43.6% |
| FOLD | New | AMICUS THERAPEUTICS INCcall | $2,865,000 | – | 300,000 | +100.0% | 0.20% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $2,811,000 | -45.2% | 25,661 | -53.2% | 0.20% | -52.3% |
| ALRN | Sell | AILERON THERAPEUTICS INC | $2,818,000 | -19.5% | 2,763,583 | -1.3% | 0.20% | -30.0% |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $2,775,000 | -53.4% | 277,551 | -33.8% | 0.20% | -59.5% |
| STRO | Sell | SUTRO BIOPHARMA INC | $2,541,000 | +1.0% | 134,575 | -0.6% | 0.18% | -11.8% |
| RLAY | New | RELAY THERAPEUTICS INCput | $2,522,000 | – | 80,000 | +100.0% | 0.18% | – |
| RLAY | New | RELAY THERAPEUTICS INCcall | $2,522,000 | – | 80,000 | +100.0% | 0.18% | – |
| LQDA | Sell | LIQUIDIA CORPORATION | $2,442,000 | -4.1% | 884,893 | -0.6% | 0.17% | -16.5% |
| SNPX | Sell | SYNAPTOGENIX INC | $2,441,000 | -17.4% | 245,629 | -18.1% | 0.17% | -28.0% |
| SYBX | Sell | SYNLOGIC INC | $2,406,000 | -27.1% | 788,818 | -7.0% | 0.17% | -36.7% |
| YMTX | Buy | YUMANITY THERAPEUTICS INC | $2,360,000 | -7.7% | 228,761 | +4.2% | 0.17% | -19.8% |
| GOSS | New | GOSSAMER BIO INCcall | $2,330,000 | – | 185,400 | +100.0% | 0.16% | – |
| INCY | Sell | INCYTE CORP | $2,247,000 | -26.9% | 32,666 | -10.6% | 0.16% | -36.3% |
| SVRA | Sell | SAVARA INC | $2,126,000 | -21.2% | 1,539,691 | -3.0% | 0.15% | -31.2% |
| ELDN | Sell | ELEDON PHARMACEUTICALS INC | $2,129,000 | -23.1% | 344,578 | -1.5% | 0.15% | -33.0% |
| NKTR | New | NEKTAR THERAPEUTICScall | $2,062,000 | – | 114,800 | +100.0% | 0.14% | – |
| EDIT | New | EDITAS MEDICINE INCcall | $2,054,000 | – | 50,000 | +100.0% | 0.14% | – |
| CDAK | New | CODIAK BIOSCIENCES INC | $1,958,000 | – | 119,895 | +100.0% | 0.14% | – |
| HSAQ | Sell | HEALTH SCIENCES ACQ CORP 2 | $1,950,000 | -4.4% | 197,173 | -1.4% | 0.14% | -17.0% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $1,890,000 | -17.9% | 23,700 | +0.2% | 0.13% | -28.5% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $1,867,000 | -25.9% | 454,346 | -21.8% | 0.13% | -35.8% |
| CRTX | Sell | CORTEXYME INC | $1,848,000 | +69.9% | 20,160 | -1.8% | 0.13% | +47.7% |
| New | MAXCYTE INC | $1,831,000 | – | 150,000 | +100.0% | 0.13% | – | |
| GMTX | Sell | GEMINI THERAPEUTICS INC | $1,701,000 | -38.3% | 421,050 | -1.3% | 0.12% | -46.2% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $1,685,000 | -27.5% | 96,576 | -0.4% | 0.12% | -36.7% |
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $1,647,000 | -43.0% | 600,693 | -34.5% | 0.12% | -50.2% |
| IFRX | Sell | INFLARX NV | $1,634,000 | -17.5% | 631,048 | -5.3% | 0.12% | -28.1% |
| VBLT | Sell | VASCULAR BIOGENICS LTD | $1,622,000 | -15.3% | 790,838 | -1.2% | 0.11% | -26.5% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $1,573,000 | – | 53,370 | +100.0% | 0.11% | – |
| New | AVALO THERAPEUTICS INC | $1,566,000 | – | 718,705 | +100.0% | 0.11% | – | |
| CYCN | Sell | CYCLERION THERAPEUTICS INC | $1,543,000 | -22.5% | 502,627 | -1.4% | 0.11% | -32.3% |
| CASI | Sell | CASI PHARMACEUTICALS INC | $1,456,000 | -25.9% | 1,223,067 | -3.6% | 0.10% | -35.2% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $1,464,000 | -53.7% | 86,712 | -20.2% | 0.10% | -59.8% |
| Sell | BELLICUM PHARMACEUTICALS INC | $1,451,000 | -12.1% | 496,756 | -0.6% | 0.10% | -23.3% | |
| VLON | Buy | VALLON PHARMACEUTICALS INC | $1,440,000 | +89.2% | 198,085 | +41.5% | 0.10% | +62.9% |
| ATHA | New | ATHIRA PHARMA INCcall | $1,407,000 | – | 150,000 | +100.0% | 0.10% | – |
| MBIO | Sell | MUSTANG BIO INC | $1,360,000 | -22.2% | 506,033 | -3.8% | 0.10% | -31.9% |
| ASND | Sell | ASCENDIS PHARMA A/Scall | $1,339,000 | +18.3% | 8,400 | -2.3% | 0.09% | +2.2% |
| RPHM | New | RENEO PHARMACEUTICALS INC | $1,303,000 | – | 175,000 | +100.0% | 0.09% | – |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $1,272,000 | -32.2% | 150,484 | -2.2% | 0.09% | -40.8% |
| DMAC | Sell | DIAMEDICA THERAPEUTICS INC | $1,247,000 | -32.5% | 311,041 | -25.1% | 0.09% | -40.9% |
| SLDB | Sell | SOLID BIOSCIENCES INC | $1,246,000 | -49.6% | 521,155 | -22.9% | 0.09% | -56.0% |
| QSI | Sell | QUANTUM SI INC | $1,204,000 | -38.6% | 144,406 | -9.7% | 0.08% | -46.5% |
| AGTC | Sell | APPLIED GENETIC TECHNOLOGIES | $1,175,000 | -27.7% | 390,394 | -6.1% | 0.08% | -36.6% |
| ANEB | Sell | ANEBULO PHARMACEUTICALS INC | $1,160,000 | -3.7% | 172,309 | -1.4% | 0.08% | -15.5% |
| MRUS | Sell | MERUS N V | $1,120,000 | +3.8% | 50,907 | -0.6% | 0.08% | -9.2% |
| PTGX | New | PROTAGONIST THERAPEUTICS INCcall | $1,083,000 | – | 61,100 | +100.0% | 0.08% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS INcall | $1,012,000 | – | 29,800 | +100.0% | 0.07% | – |
| CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $968,000 | -45.1% | 948,526 | -1.6% | 0.07% | -52.4% |
| BCLI | Sell | BRAINSTORM CELL THERAPEUTICS | $955,000 | -14.3% | 289,550 | -1.2% | 0.07% | -25.6% |
| HARP | Sell | HARPOON THERAPEUTICS INC | $879,000 | -44.2% | 111,292 | -2.0% | 0.06% | -51.2% |
| HEPA | Sell | HEPION PHARMACEUTICALS INC | $847,000 | -68.7% | 553,273 | -59.5% | 0.06% | -72.6% |
| TPST | Sell | TEMPEST THERAPEUTICS INC | $851,000 | -15.3% | 58,803 | -34.6% | 0.06% | -25.9% |
| RGLS | Sell | REGULUS THERAPEUTICS INC | $849,000 | -16.3% | 1,228,416 | -1.4% | 0.06% | -26.8% |
| ONCT | Sell | ONCTERNAL THERAPEUTICS INC | $830,000 | -12.6% | 199,180 | -0.5% | 0.06% | -24.7% |
| New | TENAX THERAPEUTICS INC | $826,000 | – | 466,261 | +100.0% | 0.06% | – | |
| New | ALTAMIRA THERAPEUTICS LTD | $803,000 | – | 399,148 | +100.0% | 0.06% | – | |
| AVIR | New | ATEA PHARMACEUTICALS INCput | $799,000 | – | 22,800 | +100.0% | 0.06% | – |
| New | ASTRIA THERAPEUTICS INC | $775,000 | – | 87,580 | +100.0% | 0.06% | – | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $770,000 | -51.2% | 42,712 | -52.4% | 0.05% | -57.5% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $747,000 | +165.8% | 214,861 | +196.5% | 0.05% | +130.4% |
| BLSA | Sell | BCLS ACQUISITION CORP | $739,000 | -6.6% | 73,789 | -1.7% | 0.05% | -18.8% |
| PBLA | Sell | PANBELA THERAPEUTICS INC | $734,000 | -24.8% | 338,382 | -1.9% | 0.05% | -34.2% |
| STTK | Sell | SHATTUCK LABS INC | $739,000 | -86.6% | 36,240 | -81.0% | 0.05% | -88.3% |
| FLACU | Sell | FRAZIER LIFESCIENCES ACQU COunit 12/09/2025 | $725,000 | -4.1% | 73,118 | -2.5% | 0.05% | -16.4% |
| IMVT | Sell | IMMUNOVANT INC | $722,000 | -63.2% | 83,046 | -55.2% | 0.05% | -67.9% |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $677,000 | – | 59,422 | +100.0% | 0.05% | – |
| PASG | Sell | PASSAGE BIO INC | $677,000 | -65.0% | 67,849 | -53.5% | 0.05% | -69.2% |
| MITO | Sell | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $651,000 | -14.5% | 478,561 | -1.9% | 0.05% | -25.8% |
| OCUP | Sell | OCUPHIRE PHARMA INC | $608,000 | -3.8% | 118,063 | -1.2% | 0.04% | -15.7% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $602,000 | – | 6,496 | +100.0% | 0.04% | – |
| SEEL | Sell | SEELOS THERAPEUTICS INC | $589,000 | -20.3% | 244,171 | -12.7% | 0.04% | -31.7% |
| AGEN | Sell | AGENUS INC | $542,000 | -4.9% | 103,192 | -0.6% | 0.04% | -17.4% |
| KLDO | New | KALEIDO BIOSCIENCES INC | $546,000 | – | 100,000 | +100.0% | 0.04% | – |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $544,000 | -94.3% | 20,743 | -93.1% | 0.04% | -95.1% |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $545,000 | +4.8% | 47,193 | -10.9% | 0.04% | -9.5% |
| CYCC | Sell | CYCLACEL PHARMACEUTICALS INC | $524,000 | -11.6% | 99,422 | -0.6% | 0.04% | -22.9% |
| INMB | Sell | INMUNE BIO INC | $517,000 | -80.0% | 26,632 | -81.9% | 0.04% | -82.8% |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $513,000 | -26.7% | 34,565 | -1.2% | 0.04% | -36.8% |
| DCTH | Buy | DELCATH SYS INC | $468,000 | -15.7% | 44,857 | +2.1% | 0.03% | -26.7% |
| IPA | Sell | IMMUNOPRECISE ANTIBODIES LTD | $459,000 | -49.2% | 73,882 | -50.7% | 0.03% | -56.2% |
| OTIC | Sell | OTONOMY INC | $399,000 | -15.5% | 208,306 | -1.5% | 0.03% | -26.3% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $377,000 | -19.4% | 196,821 | -1.6% | 0.03% | -28.9% |
| EYPT | Sell | EYEPOINT PHARMACEUTICALS INC | $380,000 | -64.8% | 36,427 | -69.7% | 0.03% | -69.0% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $349,000 | -30.8% | 49,843 | -9.2% | 0.02% | -39.0% |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $341,000 | -48.3% | 148,131 | -1.2% | 0.02% | -54.7% |
| New | AADI BIOSCIENCES INC | $335,000 | – | 11,408 | +100.0% | 0.02% | – | |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $322,000 | -6.9% | 903,680 | -4.3% | 0.02% | -17.9% |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $288,000 | +16.1% | 1,417,348 | +15.7% | 0.02% | 0.0% |
| NVAX | Sell | NOVAVAX INC | $266,000 | -52.4% | 1,283 | -51.3% | 0.02% | -57.8% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $276,000 | – | 1,461 | +100.0% | 0.02% | – |
| COGT | Sell | COGENT BIOSCIENCES INC | $258,000 | -23.7% | 30,727 | -26.4% | 0.02% | -33.3% |
| ATNX | Sell | ATHENEX INC | $228,000 | -75.3% | 76,139 | -61.9% | 0.02% | -78.7% |
| MRTX | New | MIRATI THERAPEUTICS INCput | $231,000 | – | 1,300 | +100.0% | 0.02% | – |
| Sell | APTOSE BIOSCIENCES INC | $224,000 | -35.3% | 102,089 | -1.7% | 0.02% | -42.9% | |
| IVA | Sell | INVENTIVA SAads | $202,000 | -2.4% | 14,748 | -1.7% | 0.01% | -17.6% |
| GMDA | Sell | GAMIDA CELL LTD | $122,000 | -39.3% | 31,029 | -0.4% | 0.01% | -43.8% |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $112,000 | -20.0% | 121,694 | -0.6% | 0.01% | -27.3% |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $81,000 | – | 34,131 | +100.0% | 0.01% | – |
| BXRX | Sell | BAUDAX BIO INC | $53,000 | -30.3% | 95,059 | -4.9% | 0.00% | -33.3% |
| ONTX | Sell | ONCONOVA THERAPEUTICS INC | $57,000 | -64.6% | 15,063 | -35.1% | 0.00% | -69.2% |
| ZLAB | Exit | ZAI LAB LTDcall | $0 | – | -1,600 | -100.0% | -0.02% | – |
| CHAQ | Exit | CHARDAN HEALTHCR ACQSTN 2 CO | $0 | – | -30,000 | -100.0% | -0.02% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -3,600 | -100.0% | -0.02% | – |
| VCEL | Exit | VERICEL CORPcall | $0 | – | -7,900 | -100.0% | -0.03% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -29,335 | -100.0% | -0.03% | – |
| CHMA | Exit | CHIASMA INC | $0 | – | -90,437 | -100.0% | -0.04% | – |
| SAVA | Exit | CASSAVA SCIENCES INC | $0 | – | -5,362 | -100.0% | -0.04% | – |
| ALEC | Exit | ALECTOR INCput | $0 | – | -22,300 | -100.0% | -0.04% | – |
| ALEC | Exit | ALECTOR INCcall | $0 | – | -22,300 | -100.0% | -0.04% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -21,553 | -100.0% | -0.04% | – |
| STOK | Exit | STOKE THERAPEUTICS INCput | $0 | – | -18,000 | -100.0% | -0.05% | – |
| IMVT | Exit | IMMUNOVANT INCput | $0 | – | -57,700 | -100.0% | -0.05% | – |
| CCCC | Exit | C4 THERAPEUTICS INC | $0 | – | -17,600 | -100.0% | -0.05% | – |
| FREQ | Exit | FREQUENCY THERAPEUTICS INC | $0 | – | -69,879 | -100.0% | -0.06% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -93,100 | -100.0% | -0.06% | – |
| PSTX | Exit | POSEIDA THERAPEUTICS INC | $0 | – | -85,837 | -100.0% | -0.07% | – |
| FREQ | Exit | FREQUENCY THERAPEUTICS INCput | $0 | – | -100,800 | -100.0% | -0.08% | – |
| Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -532,298 | -100.0% | -0.09% | – | |
| LLY | Exit | LILLY ELI & CO | $0 | – | -5,677 | -100.0% | -0.10% | – |
| EARS | Exit | AURIS MEDICAL HOLDING LTD | $0 | – | -404,588 | -100.0% | -0.12% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -196,208 | -100.0% | -0.13% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INCcall | $0 | – | -73,700 | -100.0% | -0.13% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -162,700 | -100.0% | -0.14% | – |
| EYPT | Exit | EYEPOINT PHARMACEUTICALS INCcall | $0 | – | -208,500 | -100.0% | -0.15% | – |
| BCEL | Exit | ATRECA INC | $0 | – | -250,000 | -100.0% | -0.17% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -124,091 | -100.0% | -0.17% | – |
| ICAD | Exit | ICAD INC | $0 | – | -128,137 | -100.0% | -0.18% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -120,895 | -100.0% | -0.19% | – |
| CVM | Exit | CEL-SCI CORPcall | $0 | – | -300,000 | -100.0% | -0.21% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.21% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -300,454 | -100.0% | -0.22% | – |
| CMLF | Exit | CM LIFE SCIENCES INC | $0 | – | -200,000 | -100.0% | -0.23% | – |
| ARPO | Exit | AERPIO PHARMACEUTICALS INC | $0 | – | -1,676,093 | -100.0% | -0.23% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -21,825 | -100.0% | -0.23% | – |
| CERC | Exit | CERECOR INC | $0 | – | -897,330 | -100.0% | -0.24% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -936,615 | -100.0% | -0.29% | – |
| RDNT | Exit | RADNET INC | $0 | – | -110,647 | -100.0% | -0.30% | – |
| IMAB | Exit | I MABsponsored ads | $0 | – | -46,066 | -100.0% | -0.31% | – |
| IMVT | Exit | IMMUNOVANT INCcall | $0 | – | -400,000 | -100.0% | -0.34% | – |
| CHAQU | Exit | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $0 | – | -400,000 | -100.0% | -0.35% | – |
| JETS | Exit | ETF SER SOLUTIONScall | $0 | – | -200,000 | -100.0% | -0.39% | – |
| FGEN | Exit | FIBROGEN INCput | $0 | – | -193,800 | -100.0% | -0.42% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -80,000 | -100.0% | -0.44% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -471,376 | -100.0% | -0.51% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INCcall | $0 | – | -203,400 | -100.0% | -0.53% | – |
| FGEN | Exit | FIBROGEN INCcall | $0 | – | -250,000 | -100.0% | -0.54% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INCput | $0 | – | -245,500 | -100.0% | -0.54% | – |
| GLPG | Exit | GALAPAGOS NVcall | $0 | – | -100,000 | -100.0% | -0.56% | – |
| ADCT | Exit | ADC THERAPEUTICS SAcall | $0 | – | -300,000 | -100.0% | -0.59% | – |
| BHC | Exit | BAUSCH HEALTH COS INCput | $0 | – | -250,000 | -100.0% | -0.59% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -295,596 | -100.0% | -0.62% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INCcall | $0 | – | -210,000 | -100.0% | -0.69% | – |
| ANVS | Exit | ANNOVIS BIO INC | $0 | – | -103,527 | -100.0% | -0.72% | – |
| ARKG | Exit | ARK ETF TRput | $0 | – | -119,900 | -100.0% | -0.90% | – |
| RAPT | Exit | RAPT THERAPEUTICS INCput | $0 | – | -350,000 | -100.0% | -0.90% | – |
| MCRB | Exit | SERES THERAPEUTICS INCcall | $0 | – | -500,000 | -100.0% | -0.96% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -674,723 | -100.0% | -1.14% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCput | $0 | – | -250,000 | -100.0% | -1.15% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -254,300 | -100.0% | -1.17% | – |
| BHC | Exit | BAUSCH HEALTH COS INCcall | $0 | – | -550,000 | -100.0% | -1.30% | – |
| SAVA | Exit | CASSAVA SCIENCES INCcall | $0 | – | -365,000 | -100.0% | -2.52% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INCcall | $0 | – | -294,400 | -100.0% | -3.85% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCput | $0 | – | -300,000 | -100.0% | -4.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.